William Blattner | Academic Influence

William Blattner's AcademicInfluence.com Rankings

William Blattner

Biology

#6127

World Rank

#8775

Historical Rank

Virology

#145

World Rank

#150

Historical Rank

Microbiology

#566

World Rank

#631

Historical Rank

biology Degrees

Download Badge

Biology

William Blattner's Degrees

Masters Microbiology Stanford University
Bachelors Biology Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is William Blattner Influential?

(Suggest an Edit or Addition)

According to Wikipedia, William A. Blattner is an American virologist and physician known for his pioneering studies on the epidemiology of human retroviruses. He is a professor of medicine at the University of Maryland School of Medicine, where he co-founded the Institute of Human Virology with Robert Gallo and Robert R. Redfield in 1996. He subsequently helped found the Institute of Human Virology, Nigeria, which has screened over 1 million Nigerians for HIV/AIDS. He retired from his position as associate director of the IHV and director of its Division of Epidemiology and Prevention on January 31, 2016. He is also the founding editor-in-chief of the Journal of Acquired Immune Deficiency Syndromes, and serves as its co-editor-in-chief along with Paul A. Volberding.

(See a Problem?)

William Blattner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection (2008) (1911)
A cancer family syndrome in twenty-four kindreds. (1988) (1284)
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome (1990) (1246)
Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection (1996) (1033)
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia (2008) (610)
The human type‐C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T‐cell leukemia/lymphoma (1982) (546)
Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. (2002) (476)
Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. (1983) (404)
An interview with Dr (2001) (350)
Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. (1996) (338)
Cancer incidence in Nigeria: a report from population-based cancer registries. (2012) (327)
Natural history of HIV-1 cell-free viremia. (1995) (282)
Non‐Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burden (1997) (268)
A prospective study of transmission by transfusion of HTLV‐I and risk factors associated with seroconversion (1992) (243)
Human T-cell leukemia virus (HTLV-I) antibodies in Africa. (1984) (224)
Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. (1990) (208)
Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians. (1992) (206)
Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor. (1984) (202)
Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. (2003) (191)
The effects of cigarette smoking on T cell subsets. A population-based survey of healthy caucasians. (1989) (181)
Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. (1990) (173)
Association of cigarette smoking with decreased numbers of circulating natural killer cells. (1989) (169)
The immediate eff ect of the Same-Sex Marriage Prohibition Act on stigma, discrimination, and engagement on HIV prevention and treatment services in men who have sex with men in Nigeria: analysis of prospective data from the TRUST cohort. (2015) (163)
Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. (2011) (162)
Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. (1998) (158)
Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors (2010) (155)
Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study. (1986) (154)
HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. (1987) (150)
Risk Factors for In Utero and Intrapartum Transmission of HIV (2005) (148)
A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204) (2011) (148)
PROGRESSION TO AIDS IN HOMOSEXUAL MEN CO-INFECTED WITH HIV AND HTLV-I IN TRINIDAD (1987) (140)
Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections (2011) (139)
Clinical, pathologic, and immunologic features of human T-lymphotrophic virus type I-associated infective dermatitis in children. (1998) (135)
Higher macrophage inflammatory protein (MIP)-1α and MIP-1β levels from CD8+ T cells are associated with asymptomatic HIV-1 infection (2000) (131)
Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. (1999) (129)
The influence of age, race, and gender on peripheral blood mononuclear-cell subsets in healthy nonsmokers (1989) (129)
Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. (1998) (128)
Cytokine induction in HTLV‐I associated myelopathy and adult T‐cell leukemia: Alternate molecular mechanisms underlying retroviral pathogenesis (1991) (126)
Testicular cancer risk among young men: role of cryptorchidism and inguinal hernia. (1985) (123)
Human retrovirology : HTLV (1990) (123)
Classification and risk assessment of individuals with familial polyposis, Gardner's syndrome, and familial non-polyposis colon cancer from [3H]thymidine labeling patterns in colonic epithelial cells. (1984) (121)
Seventh-Day Adventist vegetarians have a quiescent proliferative activity in colonic mucosa. (1985) (118)
Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. (1997) (118)
Oncogenes in radioresistant, noncancerous skin fibroblasts from a cancer-prone family. (1987) (115)
Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120: Negative Results Fail to Trigger a Phase 3 Correlates Trial (2007) (115)
Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. (1997) (114)
HTLV-I AND TROPICAL SPASTIC PARAPARESIS (1986) (110)
HIV causes AIDS. (1988) (109)
In Vivo gp41 Antibodies Targeting the 2F5 Monoclonal Antibody Epitope Mediate Human Immunodeficiency Virus Type 1 Neutralization Breadth (2009) (108)
Mortality among chemical workers exposed to benzene and other agents. (1983) (106)
HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression. (1996) (103)
Fourth-Generation Enzyme-Linked Immunosorbent Assay for the Simultaneous Detection of Human Immunodeficiency Virus Antigen and Antibody (2001) (101)
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers. (2007) (100)
Familial testicular cancer and urogenital developmental anomalies (1985) (100)
Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults (2012) (98)
Guidelines for Counseling Persons Infected with Human T-Lymphotropic Virus Type I (HTLV-I) and Type II (HTLV-II) (1993) (97)
Heterosexual transmission of human immunodeficiency virus: association with severe depletion of T-helper lymphocytes in men with hemophilia. (1987) (95)
Natural antibodies to human T‐cell leukemia/lymphoma virus in healthy venezuelan populations (1984) (94)
Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. (2003) (94)
Prevalence of Non-Tuberculous Mycobacterial Infections among Tuberculosis Suspects in Nigeria (2013) (89)
High prevalence of HIV, chlamydia and gonorrhoea among men who have sex with men and transgender women attending trusted community centres in Abuja and Lagos, Nigeria (2016) (87)
Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii. (1986) (85)
HIV prevalence estimates and AIDS case projections for the United States: report based upon a workshop. (1990) (84)
Geographic distribution of HTLV‐I and identification of a new high‐risk population (1988) (83)
Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome. (1985) (81)
Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1. (1997) (80)
Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes. (1992) (80)
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients. (1998) (79)
HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life (2013) (78)
Human retroviruses: their role in cancer. (1999) (78)
Screening for Hazardous Alcohol Use and Depressive Symptomatology Among HIV-Infected Patients in Nigeria: Prevalence, Predictors, and Association With Adherence (2010) (78)
Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria (2013) (76)
Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria (2016) (74)
Reversal of Human Immunodeficiency Virus Type 1 IIIB to a Neutralization-Resistant Phenotype in an Accidentally Infected Laboratory Worker with a Progressive Clinical Course (2001) (74)
Uptake of Treatment as Prevention for HIV and Continuum of Care Among HIV-Positive Men Who Have Sex With Men in Nigeria (2015) (74)
Development and evaluation of a human T-cell leukemia virus type I serologic confirmatory assay incorporating a recombinant envelope polypeptide (1990) (73)
A Serosurvey of Haemophilus ducreyi, Syphilis, and Herpes Simplex Virus Type 2 and Their Association With Human Immunodeficiency Virus Among Female Sex Workers in Lagos, Nigeria (1998) (69)
A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago. (2000) (67)
Type‐I HTLV antibody in urban and rural Ghana, West Africa (1984) (67)
Varied manifestations of a familial lymphoproliferative disorder. (1975) (67)
High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects. (2005) (67)
Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity. (1991) (66)
T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant (1996) (65)
Seroepidemiologic Studies Of Human T‐cell leukemia/lymphoma virus type I in Jamaica (1985) (65)
The role of hospital-based cancer registries in low and middle income countries-The Nigerian Case Study. (2012) (63)
HLA antigen frequencies in HIV-1 seropositive disease-free individuals and patients with AIDS. (1988) (63)
Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease (1998) (63)
Cervical cancer risk factors among HIV-infected Nigerian women (2013) (62)
raf involvement in the simultaneous genetic transfer of the radioresistant and transforming phenotypes. (1989) (60)
T-cell subsets in healthy teenagers: transition to the adult phenotype. (1990) (59)
Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers. (1994) (58)
Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees. (1993) (56)
Seroepidemiology of HTLV-III antibodies in a remote population of eastern Zaire. (1985) (56)
Protocol for Nearly Full-Length Sequencing of HIV-1 RNA from Plasma (2008) (55)
Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis (2015) (55)
Stigma, access to healthcare, and HIV risks among men who sell sex to men in Nigeria (2017) (55)
Efficient Processing of the Immunodominant, HLA-A*0201-Restricted Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitope despite Multiple Variations in the Epitope Flanking Sequences (1999) (55)
Neopterin: a predictive marker of acquired immune deficiency syndrome in human immunodeficiency virus infection. (1989) (54)
T cell subsets in healthy black smokers and nonsmokers. Evidence for ethnic group as an important response modifier. (1991) (54)
Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome. (1992) (53)
A survey of the human T‐cell lymphotropic virus type I (HTLV‐I) in South‐Western Colombia (1989) (52)
Licensure of screening tests for antibody to human T-lymphotropic virus type I. (1988) (52)
HIV epidemiology: past, present, and future (1991) (51)
Cytogenetic studies in human T-cell lymphoma virus (HTLV)-positive leukemia-lymphoma in the United States. (1985) (51)
SPONTANEOUS LYMPHOCYTE PROLIFERATION IN SYMPTOM-FREE HTLV-I POSITIVE JAMAICANS (1989) (51)
Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS. (2004) (51)
Malignant mesenchymoma and birth defects. Prenatal exposure to phenytoin. (1977) (50)
Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users. (1995) (50)
Improved Classification of Recent HIV-1 Infection by Employing a Two-Stage Sensitive/Less-Sensitive Test Strategy (2003) (50)
Concordance of human leukocyte antigen haplotype‐sharing, CD4 decline and AIDS in hemophilic siblings (1995) (50)
HIV‐1 prevalence and risk factors among sexually transmitted disease clinic attenders in Trinidad (1995) (49)
Cryopreservation and long‐term liquid nitrogen storage of peripheral blood mononuclear cells for flow cytometry analysis effects on cell subset proportions and fluorescence intensity (1991) (49)
Human T cell lymphotropic virus type I (HTLV-I) among female prostitutes in Kinshasa, Zaire. (1990) (49)
Evaluating Respondent-Driven Sampling as an Implementation Tool for Universal Coverage of Antiretroviral Studies Among Men Who Have Sex With Men Living With HIV (2015) (48)
Multiple myeloma in the United States, 1950–1975 (1981) (47)
Factors influencing serum neopterin and β2-microglobulin levels in a healthy diverse population (1994) (47)
Human T-cell lymphotropic virus type I (HTLV-I) seroepidemiology and risk factors in metropolitan Panamá. (1988) (47)
Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria (2012) (45)
Kaposi's sarcoma in Zaire is not associated with HTLV-III infection. (1984) (45)
HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens. (1988) (45)
Racial differences in serum immunoglobulin levels: Relationship to cigarette smoking, t‐cell subsets, and soluble interleukin‐2 receptors (1995) (44)
C-terminal fragments of gp120 and synthetic peptides from five HTLV-III strains: prevalence of antibodies to the HTLV-III-MN isolate in infected individuals. (1990) (44)
Genealogy of cancer in a family. (1979) (44)
Familial chronic lymphocytic leukemia. Immunologic and cellular characterization. (1976) (43)
Risk factors for Kaposi's sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA (2003) (43)
Human leukocyte antigen class II alleles associated with human T-cell lymphotropic virus type I infection and adult T-cell leukemia/lymphoma in a Black population. (1998) (43)
BK virus and a new type of JC virus excreted by HIV-1 positive patients in rural Tanzania (2005) (43)
A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults. (2009) (43)
HTLV‐I and HTLV‐II world‐wide distribution: Reanalysis of 4,832 immunoblot results (1993) (42)
Epidemiology of Multiple Myeloma and Related Plasma Cell Disorders: An Analytic Review (1980) (42)
Waldenström's macroglobulinemia and autoimmune disease in a family. (1980) (42)
Adult T‐Cell leukemia/lymphoma: A working point‐score classification for epidemiological studies (1994) (42)
HLA antigens in familial Hodgkin's disease (1979) (42)
Timing and determinants of mother‐to‐child transmission of HIV in Nigeria (2009) (41)
A historical study of human T lymphotropic virus type I transmission in Barbados. (1989) (40)
HTLV‐I‐associated leukemia: A model for chronic retroviral diseases (1988) (39)
A cohort study of health effects of human T-cell lymphotropic virus type I infection in Jamaican children. (2003) (39)
Prevalence of Anal High-Risk Human Papillomavirus Infections Among HIV-Positive and HIV-Negative Men Who Have Sex With Men in Nigeria (2016) (38)
Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected in Nigeria (2017) (37)
Determination of T-lymphocyte subsets on site in rural Tanzania: results in HIV-1 infected and non-infected individuals (1996) (37)
Human T lymphotropic virus type I antibody patterns: evidence of difference by age and risk group. (1988) (36)
Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans. (1992) (36)
Cell surface antigen expression in newborn cord blood lymphocytes infected with HTLV. (1983) (36)
Assessment of a rapid HIV test strategy during labor: a pilot study from Rio de Janeiro, Brazil. (2001) (36)
Racial and other characteristics of human T cell leukemia/lymphoma (HTLV-I) and AIDS (HTLV-III) in Trinidad. (1985) (35)
Determination of a unique and immunodominant epitope of human T cell lymphotropic virus type I. (1990) (35)
Elevated hypermutation levels in HIV-1 natural viral suppressors. (2013) (35)
Human T-cell lymphotropic virus type I and adult T-cell leukemia/lymphoma outside Japan and the Caribbean Basin. (1988) (34)
Trends in antiretroviral therapy and mother-infant transmission of HIV. (2000) (34)
Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II. (1991) (34)
Organization of actin‐containing cables in cultured skin fibroblasts from individuals at high risk of colon cancer (1980) (33)
AIDS and cancer registry linkage: measurement and enhancement of registry completeness. The National AIDS/Cancer Match Study Group. (1995) (33)
Screening test for HTLV-III (AIDS agent) antibodies: specificity, sensitivity, and applications. (1985) (33)
Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria (2014) (32)
Individual and Sexual Network Predictors of HIV Incidence Among Men Who Have Sex With Men in Nigeria (2019) (32)
Spontaneous lymphocyte proliferation in HTLV-II infection (1991) (32)
Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria (2013) (32)
The effect of ethnic differences on the pattern of HTLV‐I‐associated T‐cell leukemia/lymphoma (HATL) in the United States (1994) (32)
Human T-lymphotrophic viruses and diseases of long latency. (1989) (31)
Seroepidemiology of human T-cell lymphotropic virus type I infection in Taiwan. (1988) (31)
Trends in antiretroviral therapy and mother-infant transmission of HIV. The Women and Infants Transmission Study Group. (2000) (31)
Developing National Cancer Registration in Developing Countries – Case Study of the Nigerian National System of Cancer Registries (2015) (31)
Prevalence of HTLV‐I in arctic regions (1985) (30)
HLA antigen frequencies in HIV-1-related Kaposi's sarcoma. (1990) (30)
Human T‐Cell lymphotropic virus type I and severe neoplasia of the cervix in jamaica (1995) (30)
Immunologic abnormalities in melanoma-prone families. (1979) (30)
Adherence to Anti Retroviral Therapy (ART) During Muslim Ramadan Fasting (2009) (29)
HIV-1 Epidemic in the Caribbean Is Dominated by Subtype B (2009) (29)
Demographic characteristics of retroviral infections (HIV-1, HIV-2, and HTLV-I) among female professional sex workers in Lagos, Nigeria. (1993) (29)
A method for predicting individual HIV infection status in the absence of clinical information. (1988) (29)
Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy (2013) (29)
Abnormal pattern of post-gamma-ray DNA replication in radioresistant fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome. (1995) (29)
Evaluation of Chiron HIV-1/HIV-2 recombinant immunoblot assay (1996) (28)
Immunologic and virologic analyses of an acutely HIV type 1-infected patient with extremely rapid disease progression. (2001) (28)
Changing trends in clinical AIDS presentations and survival among HIV-1-infected women. (2004) (27)
Direct and indirect estimates of HIV-1 incidence in a high-prevalence population. (1998) (27)
Comparison of HIV oral fluid and plasma antibody results during early infection in a longitudinal Nigerian cohort. (2013) (27)
Familial chronic lymphocytic leukemia. (1983) (27)
Risk for HTLV-III exposure and AIDS among parenteral drug abusers in New Jersey.: ; Atlanta, GA. (1985) (27)
Virus production and spontaneous cell proliferation in HTLV-I-infected lymphocytes. (1994) (26)
Population-based monitoring of an urban HIV/AIDS epidemic. Magnitude and trends in the District of Columbia. (1992) (26)
Exposure factors for HIV-1 infection among heterosexual drug abusers in New Jersey treatment programs. (1990) (26)
Kaposi's sarcoma in three HIV-1-infected cohorts. (1990) (25)
Racial variation in serum-soluble interleukin-2 receptor levels: a population-based study of healthy smokers and nonsmokers. (1994) (25)
HIV counseling and testing and access-to-care needs of populations most-at-risk for HIV in Nigeria (2013) (25)
Low T-lymphocyte ratios in homosexual men. Epidemiologic evidence for a transmissible agent. (1984) (24)
Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects. (2011) (24)
Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria: A Randomized Controlled Trial of a Peer Support Intervention. (2015) (24)
Does human T-cell lymphotropic virus type I and human immunodeficiency virus type 1 coinfection accelerate acquired immunodeficiency syndrome? The jury is still out. (1992) (23)
Serum neopterin, beta2-microglobulin, soluble interleukin-2 receptors, and immunoglobulin levels in healthy adolescents. (1998) (23)
Characterization of acute HIV-1 infection in high-risk Nigerian populations. (2012) (23)
Cell surface antigens and function of monocytes and a monocyte-like cell line before and after infection with HIV. (1990) (22)
Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics (2017) (22)
Familial lymphoproliferative malignancy: clinical and laboratory follow-up. (1979) (22)
Retroviruses—Human T-Cell Lymphotropic Virus (1997) (22)
Diagnosis and differentiation of HIV-1 and HIV-2 infection by two rapid assays in Nigeria. (1994) (21)
HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria (2010) (21)
Lack of relation between human T-lymphotropic virus type I infection and systemic lupus erythematosus in Jamaica, West Indies. (1988) (21)
Human T‐cell lymphotropic virus type I‐associated facial nerve palsy in trinidad and tobago (1997) (20)
Challenges in treating malignancies in HIV in Nigeria (2009) (20)
Clinical manifestations of familial 13;18 translocation. (1980) (20)
An Improved Method of Fixation For Immunofluorescent Detection of SV40 T-Antigen in Infected Human Fibroblasts (1975) (19)
Molecular and immunologic analysis of a chronic lymphocytic leukemia case with antibodies against human T‐cell leukemia virus (1985) (19)
Correlates of Patient Retention in HIV Care and Treatment Programs in Nigeria. (2015) (19)
Sibling adult t‐cell leukemia/lymphoma and clustering of human t‐cell lymphotropic virus type i infection in a jamaican family (1993) (19)
Genetic variability of human immunodeficiency virus type 1 in rural northwest Tanzania. (1996) (18)
Specifics on the refinement and application of two serological assays for the detection of antibodies to HHV-8. (2000) (18)
HIV-associated lymphoma sub-type distribution, immunophenotypes and survival in an urban clinic population (2016) (18)
Non-Aids Retroviral Infections in Humans (1991) (18)
Brief Report: Trends in Antiretroviral Therapy and Mother-Infant Transmission of HIV (2000) (18)
Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments. (2002) (17)
Mortality from multiple myeloma among North Carolina furniture workers. (1985) (17)
Online Sex-Seeking Among Men who have Sex with Men in Nigeria: Implications for Online Intervention (2017) (17)
MULTIPLE MYELOMA IN SOUTH AFRICAN BLACKS (1979) (17)
Hereditary renal carcinoma and chromosomal defects. (1982) (16)
Retroviruses???Human Immunodeficiency Virus (1997) (16)
Lymph node pathology of HTLV and HTLV-associated neoplasms. (1985) (16)
Biochemical epidemiology in community-based studies: practical lessons from a study of T-cell subsets. (1989) (16)
T-cell lymphoma, tropical spastic paraparesis, and malignant fibrous histiocytoma in a patient with human T-cell lymphotropic virus, type 1. (1989) (16)
Demography and the dual epidemics of tuberculosis and HIV: Analysis of cross-sectional data from Sub-Saharan Africa (2018) (15)
Immunogenetic determinants of familial acute lymphocytic leukemia. (1978) (15)
Elevated expression of T-antigen in simian papovavirus 40-infected skin fibroblasts from individuals with cytogenetic defects. (1977) (15)
Altered cord blood gammadelta T cell repertoire in Nigeria: possible impacts of environmental factors on neonatal immunity. (2008) (15)
Anti-HIV-1 antibodies, anti-HTLV-I antibodies and neopterin levels in parenteral drug addicts in the Austrian Tyrol. (1988) (15)
Spontaneous lymphocyte proliferation is elevated in asymptomatic HTLV-I-positive Jamaicans (1990) (15)
Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria (2017) (15)
Type‐ and Group‐Specific Continuous Antigenic Determinants of HTLV. Use of Synthetic Peptides for Serotyping of HTLV‐I and ‐II Infection (1992) (14)
Type-specific prevalence of human papillomavirus DNA among Jamaican colposcopy patients. (1996) (13)
Lack of viral latency of human T-cell lymphotropic virus type I. (1991) (13)
HLA antigens in renal cell carcinoma. (1983) (13)
HTLV-I and HTLV-II coexist among the Embera and Inga Amerindians of Colombia. (1999) (12)
Markers of health status in an HTLV-I-positive cohort. (1992) (12)
Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad (2011) (12)
Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria (2014) (11)
Sequence analysis of original HIV-1 (1991) (11)
Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria (2020) (11)
Perinatal HIV Infection and Exposure and Their Association With Dental Caries in Nigerian Children (2017) (11)
Non-AIDS retroviral infections in humans. (1991) (11)
Implementation of and Early Outcomes From Anal Cancer Screening at a Community-Engaged Health Care Facility Providing Care to Nigerian Men Who Have Sex With Men (2019) (11)
Systematic variables affecting simian virus 40-induced T-antigen expression and transformation in human cells (1976) (11)
Risk factors for human T cell lymphotropic virus type II infection among the Guaymi Indians of Panama. (1999) (10)
Epidemiology of human lymphotrophic retroviruses: an overview. (1985) (10)
HTLV: epidemiology and relationship to disease. (1984) (10)
FAMILIAL LEUKÆMIA AND SV40 TRANSFORMATION (1977) (10)
Epidemiology of AIDS-Defining Malignancies (2014) (10)
Seroprevalence of human T-cell lymphotropic virus type 1 among homosexual men in the United States. (1988) (10)
Adherence to Anti-Retroviral Therapy in North Central Nigeria. (2015) (10)
Risk factors and cofactors for HTLV-I associated myelopathy / tropical spastic paraparesis (HAM/TSP) in Jamaica (1995) (10)
Human T-cell lymphotropic virus type I and neurologic disease in Panama, 1985 and 1986. (1990) (10)
Retroviruses in human leukemia (2007) (10)
Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria (2018) (9)
Experiences in establishing a PEPFAR-supported laboratory quality system in Nigeria. (2010) (9)
CEA in colonic lavage of individuals at high risk for large bowel cancer (1978) (9)
Phase I/II Randomized Trial of Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC-HIV (vCP1452) Prime/LIPO-5 Boost in Healthy, HIV-1-Uninfected Adult Participants (2014) (9)
Human T-lymphotropic virus type I tax polymorphisms in a transmission cohort: no association between sequence variation and disease manifestations. (1999) (9)
The epidemiology of human virus-associated hematologic malignancies. (1992) (9)
Changes in mortality rates from multiple myeloma. (1980) (9)
Temporal variability in immunological parameters: Peripheral blood mononuclear cell subsets, serum immunoglobulins, and soluble markers of immune system activation (1997) (9)
Performance of Genotype MTBDRplus in the Detection of Resistance to Rifampicin and Isoniazid Among Clinical Mycobacteria Isolates in Ilorin, Nigeria. (2015) (9)
HTLV-I, the prototype human retrovirus: epidemiologic features. (1985) (8)
Relation between human T-lymphotropic virus type I and neurologic diseases in Panama: 1985-1990. (1995) (8)
HIV infection and cancers other than non-Hodgkin lymphoma and Kaposi's sarcoma. (1991) (8)
Quantitative estimation by a standardized enzyme-linked immunosorbent assay of human T-cell lymphotropic virus type I antibodies in adult T-cell leukemia and acquired immune deficiency syndrome (1986) (8)
Serosorting and Sexual Risk for HIV Infection at the Ego-Alter Dyadic Level: An Egocentric Sexual Network Study Among MSM in Nigeria (2016) (8)
Adult T-cell leukemia/lymphoma in Jamaica and its relationship to human T-cell leukemia/lymphoma virus type I-associated lymphoproliferative disease. (1984) (8)
Immune status, and not HIV infection or exposure, drives the development of the oral microbiota (2020) (8)
Brief Report: Body Mass Index and Cognitive Function Among HIV-1–Infected Individuals in China, India, and Nigeria (2019) (7)
Linkage relationship between variable and constant region allotypic determinants of human immunoglobulin heavy chains (1980) (7)
HIV subtype and drug resistance patterns among drug naïve persons in Jos, Nigeria (2007) (7)
The risk of human T cell leukemia virus and viral hepatitis infection among US Marines stationed in Okinawa, Japan. (1995) (7)
The epidemiology of diseases associated with HTLV-I and HTLV-II. (1987) (7)
Elevated Plasma Levels of sCD14 and MCP-1 are associated with HIV Associated Neurocognitive Disorders among Antiretroviral Naïve Individuals in Nigeria. (2020) (7)
The HTLV-I Model and Chronic Demyelinating Neurological Diseases (1989) (6)
The relative distribution of T cell subsets is altered in Jamaican children infected with human T cell lymphotropic virus type I. (1995) (6)
Human t‐cell leukemia virus‐i and hematologic malignancies in panama (1989) (6)
Human T-cell lymphotropic virus type I infection in Barbados: results of a 20-year follow-up study. (1996) (6)
Laboratory Innovation Towards Quality Program Sustainability (2016) (6)
Cervical intraepithelial neoplasia is not associated with elevated serum neopterin levels. (1995) (6)
Immunologic Outcomes of Antiretroviral Therapy Among HIV-infected Nigerian Children and Its Association With Early Infant Feeding and Nutritional Status at Treatment Initiation (2013) (6)
Anal Microbial Patterns and Oncogenic Human Papillomavirus in a Pilot Study of Nigerian Men Who Have Sex with Men at Risk for or Living with HIV. (2019) (6)
Non-specificity of HTLV-III reactivity in sera from rural Kenya and eastern Zaire. (1986) (6)
Prognostic significance of quantitative viral markers in adult T-cell leukemia/lymphoma. (1999) (5)
9 – Epidemiology of Human T-cell Leukemia Virus Type I (HTLV-I) (1991) (5)
Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: disparate results among a cohort of intravenous drug users. (1993) (5)
Seroprevalence of HTLV-1 in chronic disease patients in Jamaica. (1994) (5)
Public Health Aspects of HIV/AIDS – Nigeria and West Africa (2008) (5)
Human lymphotropic viruses: HTLV-1 and HTLV-2. (2002) (4)
HIV-1 Antiretroviral Drug Resistance in Pregnant Women in Jamaica: A Preliminary Report. (2014) (4)
Reactive serological tests for syphilis in tropical spastic paraparesis: a dilemma. (1993) (4)
Human T-cell leukaemia virus in Africa: possible roles in health and disease. (1984) (4)
Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria (2020) (4)
SV40 T-antigen expression in cultured fibroblasts from patients with Down syndrome and their parents. (1979) (4)
Protocol for a study of nutritional factors and the low risk of colon cancer in Southern retirement areas. (1981) (4)
Cervical cancer risk factors among HIV-infected (2013) (3)
Suitability of Trinidad/Tobago as a potential site for phase III efficacy studies of HIV-1 vaccines. (1994) (3)
Cognitive Function Among Antiretroviral Treatment–Naive Individuals Infected With Human Immunodeficiency Virus Type 1 Subtype G Versus CRF02_AG in Nigeria (2018) (3)
Serological tests for Lyme disease in patients with tropical spastic paraparesis and healthy Jamaicans. (1994) (3)
No evidence of HTLV-I infection in intravenous drug abusers in West Germany. (1988) (3)
Population‐based monitoring of an urban HIV/AIDS epidemic: Magnitude and trends in the District of Columbia (1993) (3)
Cancer incidence in Nigeria from 2009 to 2013 (2015) (2)
HTLV-I infection and chronic lymphocytic leukemia. (1988) (2)
Digital cervicography and cold coagulation for cervical cancer screening in Nigeria (2012) (2)
Identification of a novel TAP2 allele in a Colombian black population: gene conversion, ancestral intermediate or convergent change? (1997) (2)
Relationship between unsupplemented vitamin A serum concentrations and measles vaccine response in Jamaican children. (1998) (2)
Increased expression of SV40 T antigen and cell division in skin fibroblast cell lines derived from a family at high risk of carcinoma (Family G of warthin) (2004) (2)
Spirochetal antibodies in tropical spastic paraparesis: their significance. (1993) (2)
HTLV-I TAX SEQUENCE VARIATION IN RIO DE JANEIRO: GEOGRAPHIC DIFFERENTIATION OF BRAZILIAN ISOLATES (1999) (2)
Mother‐to‐infant transmission of human immunodeficiency virus type 1: Association with prematurity or low anti‐gp120 (1990) (2)
A101 Pattern of mycobacterial infections and their associations with HIV among laboratory confirmed cases of pulmonary tuberculosis in Nigeria (2013) (1)
Knowledge attitude and practice of malignancies among PLWHIV in Nigeria (2012) (1)
255 HIV Related TB: Prospects and Challenges in a High Burden Area, A Case Study of Isoniazid Prophylaxis (IPT) Utilization (2009) (1)
386 – Retroviruses Other Than Human Immunodeficiency Virus (2012) (1)
AF5 High HIV-1 Prevalence, Risk Behaviors and Viral Loads Seen in Men Who Have Sex With Men Enrolled in a Community-Based Comprehensive HIV/AIDS Clinic in Nigeria (2012) (1)
AF2 Pattern of Drug Resistant Mutations Among Nigerian Patients on PEPFAR NRTINNRTI Regimens (2012) (1)
T-antigen expression in human skin fibroblasts is not regulated by an endogenous interferon response to SV40 infection (1978) (1)
JAIDS: Transitions, Evolution, and Impact. (2017) (1)
Chapter 12 Public Health Aspects of HIV/AIDS - Nigeria and West Africa (2008) (1)
Rising HIV-1 prevalence in STD clinic attenders in Jamaica: Traumatic sex and genital ulcers as risk factors (1994) (1)
Changes in HIV-2 seroprevalence in Cape Verde, west Africa. (1993) (1)
Lagos, Nigeria-New Delhi, India HIV-1 Connection Among High Class Prostitutes (1993) (1)
227 Opportunity for Scale -Up; Mobile X-ray Technology- Strengthening TB Diagnosis in HIV+ve Patients; ACTION Experience in Zaria, rural Northern Nigeria (2009) (1)
The Influence of Race on T-Cell Subset Distributions (1991) (1)
Development of a Simple and Affordable S/LS Assay to Distinguish Recent and Established HIV Infection (2005) (1)
Factors related to low t lymphocyte ratios in danish homo sexual men (1983) (1)
245 Outcome of early infant diagnosis in exposed infants in Northern Nigeria (2009) (1)
Knowledge attitude and practice of malignancies among PLWHIV in Nigeria (2012) (1)
P-A3 Drug Resistance after Second Line Failure can be Managed Using WHO Recommended Regimens in Nigeria (2014) (1)
Analysis of reverse transcriptase and protease genes of HIV for antiretroviral drug resistance in treatment-exposed Jamaican pediatrics. (2015) (1)
Human T‐cell lymphotropic virus type I (HTLV‐I) antibodies in pre‐diagnostic serum of patients with familial adult T‐cell leukemia/lymphoma (ATL) (2006) (1)
Etiology and prevention of acquired immunodeficiency syndrome: the path of interdisciplinary research. (1986) (1)
From the National Institute of Allergy and Infectious Diseases Factors Associated with the Pathogenesis of AIDS (1987) (1)
HTLV-I and HIV-1-associated neurologic abnormalities; syphilis as a confounding factor. (1989) (1)
P-B18 Prevalence of anal high-risk human papillomavirus infections among HIV-positive and HIV-negative men who have sex with men (MSM) in Nigeria (2016) (1)
President's Page—In Memoriam: Alfred S. Evans (1996) (1)
Neurocognitive impairment associated with predominantly early stage HIV infection in Nigeria. (2014) (1)
JAIDS and Human Retrovirology (1995) (1)
235 Quality ART Scale Up Through Regionalization of Laboratory Services In Nigeria (2009) (0)
HTLV-1 ASSOCIATED FACIAL NERVE PALSY IN TRINIDAD AND TOBAGO (1999) (0)
P-D15 Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders (2016) (0)
246 Interface of Public Health Implementation and Research - Challenges and Prospects - IHVN/ Action Project Experience (2009) (0)
Comment From the Editor-in-Chief (2007) (0)
Early detection of HIV: implications for prevention research. Proceedings of a conference. (2000) (0)
Quantitative Estimation bya Standardized Enzyme-Linked Immunosorbent AssayofHumanT-Cell Lymphotropic Virus TypeI Antibodies inAdultT-Cell Leukemia andAcquired Immune Deficiency Syndrome (1986) (0)
G-110 HIV-Associated Lymphoma Subtype Distribution, Immunophenotypes, and Survival (2014) (0)
Hla dr is involved in the receptor site for hiv (1987) (0)
Fixed dose combination anti-retroviral drugs had comparable immunological, virological and adherence potential with single drug combinations (2015) (0)
C-103 Genetic diversity of HIV reveals the epidemiological role of high risk groups in Nigeria (2016) (0)
Workshop on cancer epidemiology in Latin America and the Caribbean. (1992) (0)
196 Newly Identified Circulating Recombinant Form Common in Nigeria (2011) (0)
154 Responding to the challenge of AIDS Associated Cancers in Nigeria (2014) (0)
Neurocognitive Impairment Related to HIV Infection in Nigeria (P01.259) (2012) (0)
HIV/AIDS epidemiology, transmission, and risk factors (2018) (0)
Letter from William A. Blattner, National Institutes of Health to Harold Varmus (1985) (0)
Response:Research and Development in South Korea (1988) (0)
The ethnic distribution of HTLV-I and HTLV-III associated diseases in Trinidad West Indies [abstract] (1985) (0)
189 Defective HIV-1 Proviral Genomes in Natural Viral Suppressors (2009) (0)
Epidemiology of AIDS-Defi ning Malignancies (2014) (0)
Human t cell leukemia virus in africa possible roles in health and disease (1986) (0)
The Molecular Epidemiology of a Heterosexual Subtype B HIV Epidemic: the Latest Results from the Caribbean (2005) (0)
Implementation and early outcomes from an anal cancer screen and treat program in Nigeria (2018) (0)
HTLV-I and adult T-cell leukemia. (1993) (0)
Erratum to: Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria (2012) (0)
Chapter 2 Epidemiology of AIDS-Defi ning Malignancies (2015) (0)
International Retrovirology Association: President's Page (1996) (0)
Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria (2012) (0)
Racial variations in immune function and hematological parameters: description of study design and objectives (1991) (0)
INFECTION TRANSMISSION OF HTLV-1: IS VERTICAL TRANSMISSION ONE OF THE MAJOR RISK FOR ATLL DEVELOPMENT? (1999) (0)
HIV Vaccine Research Agenda: Perspectives of an HVTN Site Investigator (2005) (0)
Immunological profile in persons under antiretroviral therapy in a rural Nigerian hospital (2010) (0)
105 HIV and Viral Associated Malignancy (2011) (0)
251 Migration, Pastoralists, HIV Infection and Access to Care: The Nomadic Fulani of Northern Nigeria (2009) (0)
Uptake of condoms and lubricants remains low among Nigerian men who have sex with men despite availability and counseling at trusted community health centers (2016) (0)
HIV Associated Neurocognitive Disorders (HAND) in Nigeria: Clinical Rating versus Global Deficit Score Methods (P5.043) (2015) (0)
Treatment outcome of tuberculosis-HIV co-infection in North-central Nigeria (2011) (0)
Modesoftransmission andevidence forviral latency fromstudies ofhumanT-cell lymphotrophic virus typeIinJapanese migrant populations inHawaii (1986) (0)
Title Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja , Nigeria Permalink (2014) (0)
Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria (2017) (0)
International Retrovirology Association: HTLV & Related Viruses: The President's Page (1996) (0)
AF3 HIV Counseling and Testing and Access-to-Care Needs of Populations Most-at-Risk for HIV in Nigeria (2012) (0)
High-Risk Human Papillomavirus Persistence and Anal Microbiota Among Nigerian Men Who Have Sex With Men Living With or At Risk for HIV (2020) (0)
Combating the HIV epidemic (2020) (0)
High Prevalence of HIV, Chlamydia, and Gonorrhea among Men who have Sex with Men Attending Trusted Community Centers in Abuja and Lagos, Nigeria (2015) (0)
A106 Neurocognitive Impairment among Treatment-Naïve HIV-Infected Individuals in Nigeria (2013) (0)
Collaboration: An Collaboration: An (2010) (0)
AF6 The HACART Study: Predictors of Immuno-Virologic Outcomes and Immuno-Virologic Discordance Among Adults on HIV Antiretroviral Therapy in Nigeria (2012) (0)
Search for HIV-1 group O infection in Nigeria [letter] (1995) (0)
Continental Divide: Heidegger, Cassirer, Davos. By Peter E. Gordon. Cambridge, MA: Harvard University Press, 2010. Pp. xvi+426. $39.95. (2012) (0)
F2 Quality Assurance of Nurse Provider Led Cervical Cancer Screening in Nigeria (2012) (0)
Epidemiology of AIDS-Defi ning Malignancies (2014) (0)
BMC ID Chuka Anude (2014) (0)
Evaluating the Jaccard Similarity Index as a Persistence Measure of Multiple Anal Human Papillomavirus Among Nigerian Men Who Have Sex With Men (2021) (0)
An Inherited P53 Point Mutation in a Cancer Prone Family with Li-Fraumeni Syndrome (1991) (0)
HIV/HTLV/HHV-6 Epidemiologica Studies/ New Diagnostic Approaches (1991) (0)
Response:HIV infection in the laboratory (1988) (0)
THE OVERLLAPING OF ATLL AND TSP/HAM. EXPERIENCE OF THE BRAZILIAN ATLL STUDY GROUP (1999) (0)
243 The Use of HIVQUAL as a Quality Improvement Tool for a Large Scale HIV/AIDS Public Health Program - THE ACTION PROJECT, IHV Nigeria (2009) (0)
A-104 Gender and Neurocognitive Impairment among HIV Infected Individuals in Nigeria (2014) (0)
Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria (2014) (0)
Erratum to: Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria (2012) (0)
Malignant and Non-Malignant Diseases in Relatives of Patients with Dermatitis Herpetiformis and Coeliac Disease: A Preliminary Report (1981) (0)
Immunity in Nigerian women and the effects of pregnancy and infectious disease exposure on fetal immunity (2006) (0)
Contributors (2012) (0)

This paper list is powered by the following services:

Other Resources About William Blattner

en.wikipedia.org

What Schools Are Affiliated With William Blattner?

William Blattner is affiliated with the following schools: